Home › Small Cell Lung Cancer › Nebraska
Small Cell Lung Cancer clinical trials in Nebraska
11 studies for Small Cell Lung Cancer are looking for participants at sites in Nebraska.
Cities in Nebraska
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- University of Nebraska Medical Center, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07472517A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT03460977Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Nebraska Cancer Specialists, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Oncology Hematology West PC, Omaha
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 17, 2026 · NCT07778316The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Nebraska Medical Center Buffet Cancer Center, Omaha
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT04585750Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Nebraska Hematology-Oncology (NHO), Lincoln
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06712355A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Nebraska Cancer Specialists, Grand Island
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- University of Nebraska Medical Center, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06203210Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Nebraska Cancer Specialists, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.